Sportradar heads into the week with a widening disconnect: short sellers have spent a month rebuilding positions while the stock slides, yet the options market shows almost no fear, and JP Morgan just raised its price target.
The short interest story is the one worth unpacking first. Estimated shares short have climbed roughly 46% over the past month, from around 7.3 million in mid-June to 11.2 million now — a substantial build in absolute terms. But the lending market puts that in context. Availability is running at 603%, meaning for every share already borrowed there are roughly six more sitting in the lending pool ready to go. Cost to borrow has eased sharply too, dropping 26% on the week to just 0.50% — near the lowest level in the 30-day window. This is not a squeeze setup. The short build looks deliberate rather than desperate, with ample room for more without squeezing existing positions. Days-to-cover on FINRA's most recent fortnightly data sits at 5.6 days, which is moderate but not alarming for a stock of this size.
Options positioning tells an almost eerily calm story. The put/call ratio is 0.28, sitting right on its 20-day average and barely a fraction of a standard deviation below it. That's far from the 52-week high of 0.75. Whatever the short sellers see, options traders are not hedging into it. The muted PCR, combined with loose borrow conditions, makes the overall positioning look opportunistic rather than panicked.
The Street is split in an interesting way. JP Morgan's Daniel Politzer raised his target from $16 to $17 this morning — keeping a Neutral rating, but nudging higher just as the stock trades at $15.03. Citizens lowered its target from $26 to $24 last week, still with a Market Outperform. The consensus target averages $18.54, implying roughly 23% potential upside at current levels, though the range is wide: Jefferies sits at $13 (Hold), while UBS, Guggenheim, and Citigroup all have Buy ratings with targets in the $23–$30 range. The bear case centres on rising sports rights fees squeezing margins and limited pricing power with sportsbook operators. The bull case rests on the company's multi-product Kalshi deal and the long runway in US prediction markets and in-game wagering. The ORTEX short score of 47.7 places SRAD near the middle of the universe — not a high-conviction short signal either way.
One ownership detail stands out. CEO Carsten Koerl added 935,190 shares in the most recent reported period, lifting his holding to 10.6 million shares. That's a meaningful personal conviction signal. Several smaller managers — Greenhouse Funds, Manulife, Balyasny, Alyeska, Spruce House — all appear to have initiated or materially added positions in Q1. Canada Pension Plan remains the anchor at 21.9% of shares. Insider sales in the period have been routine award-related disposals at low significance scores, with no discretionary selling of note.
On earnings, the next print is scheduled for August 19. The last release in May produced a near-flat 1-day move of +0.3%, recovering to +5.3% by day five. The prior print in late April was harder — down 9.4% on the day. With DKNG falling 6.3% on the week and GENI off 0.8%, the gaming and sports-data complex has been under broader pressure, making the August print a read on whether the sector is repricing for the rights-cost headwinds the bears are flagging or absorbing them.
The key thing to watch between now and August 19 is whether the short build continues at the same pace — another month at this rate would push estimated SI well above 15 million shares — and whether the borrow market tightens as a result, or whether availability stays as loose as it is today.
See the live data behind this article on ORTEX.
Open SRAD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
